Anyone who can afford to risk some extra cash should be all over this share as the return potential is massive within next 12 months...
We are talking about 20x plus minimum from current valuation if Neuron is any benchmark...or if their slides showing deal values in renal space is any benchmark....
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing, page-75
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $223.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $661.1K | 1.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 48862 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 71618 | 6 |
View Market Depth
| Last trade - 14.16pm 09/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |